Biophytis Announces Its Participation in Two Major Investor Conferences in January, In the United States and In France: The JP Morgan Healthcare Conference and The Invest Securities Biomed

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / January 5, 2023 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "company") a clinical-stage biotechnology company focused

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States ,Paris ,France General ,France ,Massachusetts ,San Francisco ,California ,America ,American , ,Exchange Commission ,Euronext Growth Paris ,Healthcare Conference ,Invest Securities Biomed Event ,Securitie Biomed Event ,Latin America ,Duchenne Muscular Dystrophy ,Euronext Growth ,American Depositary Shares ,Nasdaq Capital Market ,Year Financial Report ,Biophytis ,Nnounces ,Participation ,Major ,Investor ,Conferences ,January ,United ,States ,Organ ,Healthcare ,Conference ,Invest ,Securities ,Abiomed ,